These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1139863

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K.
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [Abstract] [Full Text] [Related]

  • 3. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
    Reidenberg MM, Vesell ES.
    Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of tricyclic antidepressants on drug metabolism.
    Pond SM, Graham GG, Birkett DJ, Wade DN.
    Clin Pharmacol Ther; 1975 Aug; 18(2):191-9. PubMed ID: 50160
    [Abstract] [Full Text] [Related]

  • 7. The effect of different sulfonamides on phenytoin metabolism in man.
    Hansen JM, Kampmann JP, Siersbaek-Nielsen K, Lumholtz IB, Arrøe M, Abildgaard U, Skovsted L.
    Acta Med Scand Suppl; 1979 Aug; 624():106-10. PubMed ID: 284708
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.
    Back DJ, Tjia JF.
    Br J Pharmacol; 1985 May; 85(1):121-6. PubMed ID: 4027461
    [Abstract] [Full Text] [Related]

  • 9. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M.
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine.
    Watanabe H, Hastings JW.
    Biochim Biophys Acta; 1990 Jun 26; 1017(3):229-34. PubMed ID: 2372557
    [Abstract] [Full Text] [Related]

  • 11. Carbenoxolone interactions in man--preliminary report.
    Thornton PC, Papouchado M, Reed PI.
    Scand J Gastroenterol Suppl; 1980 Jun 26; 65():35-9. PubMed ID: 6937939
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W, Breimer DD, Richter E.
    Eur J Clin Pharmacol; 1975 Dec 19; 9(2-3):219-27. PubMed ID: 1233266
    [Abstract] [Full Text] [Related]

  • 15. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y, Hanano M, Sugiyama Y, Iga T.
    J Pharmacokinet Biopharm; 1985 Oct 19; 13(5):477-92. PubMed ID: 3938813
    [Abstract] [Full Text] [Related]

  • 16. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB, Vesell ES.
    Clin Pharmacol Ther; 1974 Dec 19; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract] [Full Text] [Related]

  • 17. Effect of pirprofen on protein binding of warfarin and tolbutamide in human plasma.
    Luders RC, Chao D.
    J Pharm Sci; 1981 Dec 19; 70(12):1370-1. PubMed ID: 7320855
    [Abstract] [Full Text] [Related]

  • 18. Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man.
    Hansen JM, Siersboek-Nielsen K, Skovsted L.
    Clin Pharmacol Ther; 1971 Dec 19; 12(3):539-43. PubMed ID: 5567804
    [No Abstract] [Full Text] [Related]

  • 19. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO, Foenander T, Wanwimolruk S, Gallus AS, Birkett DJ.
    Eur J Clin Pharmacol; 1982 Dec 19; 22(4):321-6. PubMed ID: 7106168
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.
    Zilly W, Breimer DD, Richter E.
    Eur J Clin Pharmacol; 1977 Apr 20; 11(4):287-93. PubMed ID: 862650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.